Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Human mast cells (MCs) and eosinophils were first described and named by Paul Ehrlich. These cells have distinct myeloid progenitors and differ morphologically, ultrastructurally, immunologically, biochemically and pharmacologically. However, MCs and eosinophils play a pivotal role in several allergic disorders. In addition, these cells are involved in autoimmune disorders, cardiovascular diseases and cancer. MCs are distributed throughout all normal human tissues, whereas eosinophils are present only in gastrointestinal tract, secondary lymphoid tissues, and adipose tissue, thymus, mammary gland and uterus. However, in allergic disorders MCs and eosinophils can form the “allergic effector unit”. Moreover, in several tumors, MCs and eosinophils can be found in close proximity. Therefore, it is likely that MCs have the capacity to modulate eosinophil functions and vice versa. For example, IL-5, stem cell factor (SCF), histamine, platelet activating factor (PAF), prostaglandin D2 (PGD2), cysteinyl leukotrienes and vascular endothelial growth factors (VEGFs), produced by activated MCs, can modulate eosinophil functions through the engagement of specific receptors. On the other side, eosinophil cationic proteins such as eosinophil cationic protein (ECP) and major basic protein (MPB), nerve growth factor (NGF) and VEGFs released by activated eosinophils can modulate mast cell functions. These bidirectional interactions between MCs and eosinophils might be relevant not only in allergic diseases, but also in several inflammatory and neoplastic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799 · cited 1×
“Although human MCs are distributed throughout, nearly all normal tissues (39, 40) their density is increased at sites of allergic reactions (1), autoimmune disorders (4, 5), and at the edge of several solid (41–55) and hematologic tumors (56–64).”
BackgroundLambrecht, B. N., & Hammad, H. (2015) · Nature Immunology · doi:10.1038/ni.3049 · Cited by 1,673 · cited 1×
“Asthma Asthma is a chronic inflammatory disorder of the airways in which cells of the innate and adaptive immune system act together with epithelial cells to cause bronchial hyperreactivity, mucus overproduction, airway wall remodeling, angiogenesis, and airway narrowing (123, 130, 131).”
BackgroundMast Cells, Mastocytosis, and Related Disorders
Theoharides, T. C., Valent, P., & Akin, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1409760 · Cited by 518
Carretero, R., Sektioglu, I. M., Garbi, N., Salgado, O. C., Beckhove, P., & Hämmerling, G. J. (2015) · Nature Immunology · doi:10.1038/ni.3159 · Cited by 501
Bousquet, J., Cabrera, P., Berkman, N., Buhl, R., Holgate, S., Wenzel, S., Fox, H., Hedgecock, S., Blogg, M., & Cioppa, G. D. (2005) · Allergy · doi:10.1111/j.1398-9995.2004.00770.x · Cited by 401 · cited 1×
“Indeed, anti-IgE therapy with omalizumab, added to medium- or high-dose inhaled glucocorticoids, has proven effective in the treatment of patients with moderate-to-severe and severe allergic (IgE-mediated) asthma by reducing exacerbations and associated use of systemic glucocorticoids in addition to improving other cl…”
BackgroundBodemer, C., Hermine, O., Palmérini, F., Yang, Y., Grandpeix-Guyodo, C., Leventhal, P. S., Hadj-Rabia, S., Nasca, L., Georgin-Lavialle, S., Cohen-Akenine, A., et al. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.281 · Cited by 397 · cited 1×
“Cutaneous mastocytosis is associated with gain-of-function Kit mutations in approximately 8% of cases (217).”
BackgroundThe cardiovascular manifestations of the hypereosinophilic syndrome
Parrillo, J. E., Borer, J. S., Henry, W. L., Wolff, S. M., & Fauci, A. S. (1979) · The American Journal of Medicine · doi:10.1016/0002-9343(79)90227-4 · Cited by 314
Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli
Kobayashi, H., Gleich, G. J., Butterfield, J. H., & Kita, H. (2002) · Blood · doi:10.1182/blood.v99.6.2214 · Cited by 169 · cited 1×
“Nerve growth factor (NGF), produced by both MCs (114, 115) and eosinophils (116, 117), is increased in patients with asthma (118).”
BackgroundInvolvement of eosinophils in the anti-tumor response
Gatault, S., Legrand, F., Delbeke, M., Loiseau, S., & Capron, M. (2012) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-012-1288-3 · Cited by 132
Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation
Luna-Gomes, T., Magalhães, K. G., Mesquita-Santos, F. P., Bakker-Abreu, I., Samico, R. F., Molinaro, R., Calheiros, A. S., Diaz, B. L., Bozza, P. T., Weller, P. F., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101806 · Cited by 87
Cited by
Role of Mast Cells in Shaping the Tumor Microenvironment
Komi, D. E. A., & Redegeld, F. A. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08753-w · Cited by 362
Interleukin-5 in the Pathophysiology of Severe Asthma.
Pelaia, C., Paoletti, G., Puggioni, F., Racca, F., Pelaia, G., Canonica, G. W., & Heffler, E. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01514 · Cited by 337
Eosinophils from Physiology to Disease: A Comprehensive Review
Ramirez, G. A., Yacoub, M.-R., Ripa, M., Mannina, D., Cariddi, A., Saporiti, N., Ciceri, F., Castagna, A., Colombo, G., & Dagna, L. (2018) · BioMed Research International · doi:10.1155/2018/9095275 · Cited by 316
Inflammation, not Cholesterol, Is a Cause of Chronic Disease
Tsoupras, A., Lordan, R., & Zabetakis, I. (2018) · Nutrients · doi:10.3390/nu10050604 · Cited by 315
Eosinophils: The unsung heroes in cancer?
Varricchi, G., Galdiero, M. R., Loffredo, S., Lucarini, V., Marone, G., Mattei, F., Marone, G., & Schiavoni, G. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1393134 · Cited by 280
Self-citationHwang, M., Canzoniero, J. V., Rosner, S., Zhang, G., White, J. R., Belcaid, Z., Cherry, C., Balan, A., Pereira, G., Curry, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004688 · Cited by 150
Selected recent advances in understanding the role of human mast cells in health and disease
Levi-Schaffer, F., Gibbs, B. F., Hallgren, J., Pucillo, C., Redegeld, F., Siebenhaar, F., Vitte, J., Mezouar, S., Michel, M., Puzzovio, P. G., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.030 · Cited by 51
Self-citation
Metadata
- Authors
- Galdiero, M. R., Varricchi, G., Seaf, M., Marone, G., Levi-Schaffer, F., & Marone, G.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2017-07-24
- Volume
- 4
- Pages
- 103-103
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W2736610297
- Cited by
- 121
- References
- 10
- FWCI
- 4.60
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.